The success of algorithms is indisputable. They are the invisible conductors of precision in a world overloaded with data. From predicting weather and optimizing traffic to diagnosing diseases and ...
UroGen Pharma shows strong growth with RTGel technology, FDA approvals for JELMYTO and ZUSDURI, and accelerating 2026 revenue outlook. See why URGN stock is a buy.
The scientists stimulated the brain using electrodes implanted on its surface. Blind and sighted participants could "see" ...